How low is too low? Experts debate blood pressure targets in post-SPRINT era: Two studies provide evidence for the benefits and costs of incorporating lower systolic blood pressure targets into clinical practice

Following the landmark SPRINT trial, there is a growing body of evidence for reducing systolic blood pressure targets, resulting in